Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2025
Q3
Sell
-735,814
Closed -$5.49M 323
2025
Q2
$5.49M Sell
735,814
-388,581
-35% -$2.41M 0.02% 545
2025
Q1
$6.84M Hold
1,124,395
0.02% 470
2024
Q4
$8.75M Hold
1,124,395
0.03% 405
2024
Q3
$9.12M Buy
1,124,395
+251,178
+29% +$2.06M 0.03% 408
2024
Q2
$6.03M Buy
873,217
+639,855
+274% +$8.62M 0.02% 491
2024
Q1
$4.13M Buy
+233,362
New +$3.7M 0.01% 599

Other funds holding CYRX

Axa's CYRX Position: Q3 2025 in Review

Axa sold out of CryoPort (CYRX) in Q3 2025, closing a stake of 735,814 shares — an estimated $5.49M sold.

Axa first reported a position in CYRX in Q1 2024 and held it in 6 quarters. The position peaked at $9.12M in Q3 2024. 160 funds tracked by Wall St. Rank hold CYRX as of Q3 2025.

  • Axa reported no remaining CryoPort position as of Q3 2025 after selling out during the quarter.
  • Axa sold 735,814 CryoPort shares in Q3 2025, an estimated $5.49M.
  • Axa first reported a position in CryoPort in Q1 2024 and held it in 6 quarters.
  • Axa's CryoPort position peaked at $9.12M in Q3 2024.
  • 160 funds tracked by Wall St. Rank held CryoPort as of Q3 2025.

Based on Axa's 13F filing for Q3 2025, filed 14 Nov 2025.